BLOO7 schreef op 12 augustus 2020 10:58:
Dit is inderdaad de deadline.
Alles over PRV
Gilead had er 80 miloen dollar voor over.www.gilead.com/news-and-press/press-r...
VIII. PRIORITY REVIEW DESIGNATIONAn application for a drug will receive priority review designation if it is for a drug that treats a
serious condition and, if approved, would provide a significant improvement in safety or
In addition, specific statutory provisions provide for priority review for various
types of applications, described in section IV. A priority designation is intended to direct overall
attention and resources to the evaluation of such applications. This section describes the
qualifying criteria and the features of priority review designation. Appendix 1 describes the
process for priority review designation.www.fda.gov/media/86377/download
Filgotinib voldoet aan beide voorwaarden.
Ik kan geloven dat Abbvie dat niet ziet zitten.
Hup Gala Hup